分泌促肾上腺皮质激素的垂体瘤中基质金属蛋白酶-9、垂体瘤转化基因、高迁移率族蛋白A2和Ki-67的表达及其与肿瘤复发的关联
该回顾性研究纳入55例经蝶窦腺瘤切除术后长期缓解的散发性库欣病患者,随访33-59个月(平均41.8个月),按复发状态分为非复发组(n=28)和复发组(n=27),采用免疫组化检测MMP-9、PTTG、HMGA2和Ki-67表达。结果显示复发组MMP-9表达较非复发组显著增高(P=0.022),且与无复发生存间期强相关(P=0.007,相关系数=-0.354);PTTG、HMGA2和Ki-67在两组间无显著差异。结论认为MMP-9水平较高的ACTH分泌性垂体瘤与更高的复发率和更短的无复发生存间期相关,MMP-9可能是预测肿瘤复发的有价值工具。
要点
- 复发组MMP-9表达较非复发组显著增高(P=0.022)。
- MMP-9表达与无复发生存间期强相关(P=0.007,相关系数=-0.354)。
- PTTG、HMGA2和Ki-67在复发组与非复发组间无显著差异。
核心结论
- MMP-9水平较高的ACTH分泌性垂体瘤与更高的复发率和更短的无复发生存间期相关。
- MMP-9可能是预测ACTH分泌性垂体瘤复发的有价值工具。
研究设计与样本
- 回顾性研究,纳入55例经蝶窦腺瘤切除术后长期缓解的散发性库欣病患者,收集55份ACTH分泌性垂体瘤标本和2份正常垂体组织。
- 随访33-59个月(平均41.8个月),按复发状态分为非复发组(n=28)和复发组(n=27)。
- 采用免疫组化检测并量化MMP-9、PTTG、HMGA2和Ki-67的表达,评估其与临床病理特征及肿瘤复发的关联。
主要发现
- 复发组MMP-9表达较非复发组显著增高(P=0.022)。
- MMP-9表达与无复发生存间期强相关(P=0.007,相关系数=-0.354)。
- PTTG、HMGA2和Ki-67在复发组与非复发组间表达无显著差异。
- 2份正常垂体组织中未检测到MMP-9、PTTG、HMGA2或Ki-67的表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Matrix metalloproteinase-9 (MMP-9), pituitary tumor transforming gene (PTTG), and high mobility group A 2 (HMGA2) play important roles in the tumorigenesis of adrenocorticotrophic hormone (ACTH)-secreting pituitary tumors, but their associations with tumor recurrence after transsphenoidal adenomectomy remain unclear. The aim of the study was to investigate the immunohistochemical expression profiles of MMP-9, PTTG, HMGA2, and Ki-67 in recurrent and nonrecurrent ACTH-secreting pituitary tumors and to identify their associations with tumor behavior and recurrence status. METHODS: A retrospective study was performed including 55 patients with sporadic Cushing's disease with long-term remission after transsphenoidal adenomectomy. Fifty-five ACTH-secreting pituitary tumor specimens and 2 normal pituitary glands were collected. After an intensive follow-up (33-59 months, mean 41.8 months), patients were divided into 2 groups based on their recurrence status: the nonrecurrent group (n = 28) and the recurrent group (n = 27). The expression of MMP-9, PTTG, HMGA2, and Ki-67 in each sample was examined and quantified by immunohistochemistry. The association between MMP-9, PTTG, HMGA2, and Ki-67 expression and clinicopathologic characteristics and tumor recurrence were evaluated. RESULTS: There was a significantly increased expression of MMP-9 in the recurrent group compared with the nonrecurrent group (P = 0.022), and this was strongly associated with the recurrence-free interval (P = 0.007, correlation coefficient. = -0.354). PTTG, HMGA2, and Ki-67 expression were not significantly different between the recurrent group and the nonrecurrent group. No expression of MMP-9, PTTG, HMGA2, or Ki-67 was detected in the 2normal pituitary glands. CONCLUSIONS: ACTH-secreting pituitary tumors with greater levels of MMP-9 were associated with a greater recurrence rate and a shorter recurrence-free interval. MMP-9 could be a valuable tool for predicting recurrence of ACTH-secreting pituitary tumors.
引用
- Liu X, Feng M, Zhang Y, et al. Expression of Matrix Metalloproteinase-9, Pituitary Tumor Transforming Gene, High Mobility Group A 2, and Ki-67 in Adrenocorticotropic Hormone-Secreting Pituitary Tumors and Their Association with Tumor Recurrence. World Neurosurg. 2018. PMID: 29432944. doi:10.1016/j.wneu.2018.01.214
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。